For patients on low doses (5 to 10 units), this represents 5 to 20 percent of their intended dose
Transitional housing programs and deaddiction centers can also offer valuable assistance.
Among GLP-1 medications specifically, semaglutide has one of the longest half-lives: Exenatide (Byetta): approximately 2.4 hours, requires twice-daily injections Liraglutide (Saxenda, Victoza): approximately 13 hours, requires once-daily injections Dulaglutide (Trulicity): approximately 5 days, requires once-weekly injections Semaglutide (Ozempic, Wegovy): approximately 7 days, requires once-weekly injections Tirzepatide (Mounjaro, Zepbound): approximately 5 days, requires once-weekly injections Semaglutides seven-day half-life ties it with dulaglutide for the longest among currently approved GLP-1 medications
It's a metabolic one
However, certain clinical scenarios require careful consideration and may benefit from specialist input before initiating treatment
Sedentary individuals can stay toward the lower end of the recommended protein intake range